|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Norvasc (Amlodipine). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (462)
Cases resulting in a serious event (439)
Cases resulting in death (26)
Cases resulting in life threatening events (33)
Cases resulting in hospitalization (158)
Cases resulting in disability (31)
Cases resulting in other serious reactions (320)
Below is a sample of reports where side effects / adverse reactions may be related to Norvasc (Amlodipine). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 11 year old male receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-10-31
Patient: 11 year old male
Adverse reactions / side effects: Aplasia Pure RED Cell
Suspect drug(s):
Norvasc (Amlodipine)
Other drugs received by patient: Valproate Sodium; Lisinopril
Adverse event in male receiving Norvasc (Amlodipine)
Reported by a physician from United States on 2007-10-31
Patient: male, weighing 90.9 kg (200.0 pounds)
Adverse reactions / side effects: X-RAY Limb Abnormal, Joint Sprain
Suspect drug(s):
Norvasc (Amlodipine)
Other drugs received by patient: Colchicine; Indomethacin; Cozaar
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a individual with unspecified qualification from United States on 2007-10-31
Patient: female, weighing 62.6 kg (137.7 pounds)
Adverse reactions / side effects: LIP Swelling, White Blood Cell Count Decreased, Pain, Stomach Discomfort, Headache, Weight Increased, Malaise, Blood Potassium Decreased, Dyspepsia, Heart Rate Increased, Chest Pain, Blood Pressure Inadequately Controlled, Palmar Erythema, Renal Pain
Suspect drug(s):
Diphenhydramine HCL
Administration route: Oral
Indication: Pain
Start date: 2004-11-29
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
End date: 2005-02-01
Other drugs received by patient: Synthroid; Dyazide; Antithyroid Preparations; Synthroid
Adverse event in male receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-10-30
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease, Respiratory Failure, Lung Abscess
Adverse event resulted in: death
Suspect drug(s):
Biofermin R
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Erythrocin
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Ferromia
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Finibax
Finibax
Indication: Lung Abscess
Itraconazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Juzen-Taiho-TO
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Mucosta
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Norvasc
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Slow-K
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sucralfate
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Zantac
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Cravit
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-30
Patient: female
Adverse reactions / side effects: Gastrointestinal Infection, Toxic Epidermal Necrolysis
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Apresoline
Administration route: Oral
Indication: Hypertension
Baktar
Administration route: Oral
Indication: Interstitial Lung Disease
Cravit
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Dormicum
Indication: Sedation
Lansoprazole
Indication: Gastric Ulcer
Lansoprazole
Administration route: Oral
Norvasc
Administration route: Oral
Indication: Hypertension
Olmetec
Administration route: Oral
Indication: Hypertension
Omegacin
Indication: Interstitial Lung Disease
Pentazocine Lactate
Indication: Sedation
Prodif
Indication: Interstitial Lung Disease
Voltaren
Indication: Hyperthermia
Other drugs received by patient: Rheumatrex; Rimatil; Solu-Medrol; Elaspol; Predonine; Predonine
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a individual with unspecified qualification from Brazil on 2007-10-30
Patient: female
Adverse reactions / side effects: Drug Ineffective, Impaired Work Ability, Ill-Defined Disorder, Palpitations, Diarrhoea, Pulmonary Oedema, Oedema, Arterial Occlusive Disease, Depression, Myocardial Infarction, Blood Glucose Increased, Haematoma
Adverse event resulted in: disablity
Suspect drug(s):
Aldactone
Dosage: (qd), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Caduet
Dosage: 10/5 mg (bid),per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Coristina D (Acetysalicylic Acid, Cafffeine, Phenylephrine Hydrochlori
Indication: Drug USE FOR Unknown Indication
Diabinese
Dosage: 500 mg (250 mg,bid),per oral
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Norvasc
Dosage: 5 mg (5 mg,qd),per oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2004-01-01
End date: 2006-01-01
Olmesartan Medoxomil
Dosage: 20 mg (20 mg,qd),per oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-01-01
Other drugs received by patient: Insulin (Insulin) (-Injection) (Insulin)
Adverse event in 70 year old male receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from Japan on 2007-10-29
Patient: 70 year old male
Adverse reactions / side effects: Hypertension
Suspect drug(s):
Norvasc (Amlodipine)
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Hypertension
Suspect drug(s):
Norvasc (Amlodipine)
Adverse event in male receiving Norvasc (Amlodipine)
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: male
Adverse reactions / side effects: Dysarthria, Facial Paresis, Muscular Weakness
Adverse event resulted in: hospitalization
Suspect drug(s):
Aggrenox
Dosage: blinded study drug
Administration route: Oral
Indication: Cerebrovascular Accident Prophylaxis
Clopidogrel
Dosage: blinded study drug
Administration route: Oral
Indication: Cerebrovascular Accident Prophylaxis
Hydrochlorothiazide
Indication: Hypertension
Micardis
Dosage: blinded study drug
Administration route: Oral
Indication: Cerebrovascular Accident Prophylaxis
Norvasc
Indication: Hypertension
Placebo (Blind)
Dosage: blinded study drug
Administration route: Oral
Indication: Cerebrovascular Accident Prophylaxis
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Osteoporosis, Cardiac Pacemaker Insertion, Blood Cholesterol Increased
Suspect drug(s):
Norvasc (Amlodipine)
Other drugs received by patient: Cordarone; Coumadin
Adverse event in 79 year old female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: 79 year old female
Adverse reactions / side effects: Asthma, Cataract, Erythema, Neuropathy Peripheral, Staphylococcal Infection, Fungal Infection, Oedema Peripheral, Dehydration, Aspergillosis, Hypertension, Depressed Mood
Adverse event resulted in: disablity
Suspect drug(s):
Alprazolam
Catapres-TTS-1
Edecrin
Isradipine
Nexium
Norvasc
Other drugs received by patient: Metoprolol; Neurontin
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: female, weighing 81.8 kg (180.0 pounds)
Adverse reactions / side effects: Blood Pressure Increased, Irritability, Speech Disorder, Chest Pain, Disturbance in Attention, Feeling Abnormal
Suspect drug(s):
Lipitor
Indication: Blood Cholesterol Increased
Start date: 2007-10-08
End date: 2007-10-14
Norvasc
Indication: Hypertension
Other drugs received by patient: Lodine; Protonix; Prednisone
Adverse event in 84 year old male receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: 84 year old male
Adverse reactions / side effects: Onychoclasis
Suspect drug(s):
Advair Diskus 100 / 50
Dosage: 1puff twice per day
Indication: Asthma
Norvasc
Dosage: 5mg unknown
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Metoprolol; Albuterol; Simvastatin
Adverse event in male receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from Korea, Republic of on 2007-10-26
Patient: male
Adverse reactions / side effects: Pain in Extremity, Visual Acuity Reduced, Sexual Dysfunction, Cerebral Haemorrhage
Suspect drug(s):
Norvasc (Amlodipine)
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from Brazil on 2007-10-26
Patient: female
Adverse reactions / side effects: Syncope, Dyspnoea, Injection Site Haematoma, Coagulopathy, Oedema, Arterial Occlusive Disease, Pulmonary Oedema, Depression, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Hypertension
Caduet
Dosage: text:10mg/5mg;20mg/10mg
Administration route: Oral
Indication: Hypertension
Coristina D
Administration route: Oral
Indication: Influenza
Diabinese
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 1996-01-01
End date: 2004-11-30
Insulin
Indication: Diabetes Mellitus
Start date: 2004-11-01
Norvasc
Administration route: Oral
Start date: 2004-01-01
End date: 2006-01-01
Novonorm
Olmetec
Administration route: Oral
Indication: Hypertension
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a physician from United States on 2007-10-25
Patient: female, weighing 86.2 kg (189.6 pounds)
Adverse reactions / side effects: Blood Pressure Inadequately Controlled, Headache, Cerebrovascular Accident
Adverse event resulted in: hospitalization
Suspect drug(s):
Amlodipine
Administration route: Oral
Indication: Hypertension
Norvasc
Start date: 2007-01-15
End date: 2007-04-01
Other drugs received by patient: Lantus; Metformin; Glipizide
Adverse event in 59 year old female receiving Norvasc (Amlodipine)
Reported by a individual with unspecified qualification from Japan on 2007-10-25
Patient: 59 year old female
Adverse reactions / side effects: Toxic Epidermal Necrolysis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Apresoline
Dosage: 100 mg (50 mg, 2 in 1 d), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2007-07-23
End date: 2007-08-03
Baktar (Sulfamethoxazole, Trimethoprim) (Sulfamethoxazole, Trimethopri
Dosage: 2 gm (1 gm, 2 in 1 d), per oral
Administration route: Oral
Indication: Interstitial Lung Disease
Start date: 2007-07-25
End date: 2007-08-01
Cravit (Levofloxacin) (Tablet) (Levofloxacin)
Dosage: 400 mg (200 mg, 1 in 1 d), per oral
Administration route: Oral
Indication: Toxic Epidermal Necrolysis
Start date: 2007-08-08
End date: 2007-08-12
Dormicum (Midazolam Hydrohloride) (Injection) (Midazolam Hydrochloride
Dosage: continuous intravenous (not otherwise specified)
Indication: Sedation
Start date: 2007-07-23
End date: 2007-07-28
Norvasc
Dosage: 5 mg ( 5 mg, 1 in 1 d) per oral
Administration route: Oral
Indication: Hypertension
Start date: 2007-08-08
End date: 2007-08-21
Olmesartan Medoxomil
Dosage: 20 mg (20 mg, 1 in 1 d), per oral
Administration route: Oral
Indication: Hypertension
Start date: 2007-08-08
End date: 2007-08-21
Omegacin (Biapenem) (Injection) (Biapenem)
Dosage: 600 mg (300 mg, 2 in 1 d), intravenous drip
Indication: Interstitial Lung Disease
Start date: 2007-07-23
End date: 2007-08-04
Prodif (Injection)
Dosage: 800 mg, 400 mg (2 in 1 d), intavenous (not otherwise specified)
Indication: Interstitial Lung Disease
Start date: 2007-07-23
End date: 2007-08-04
Sosegon (Pentazocine) (Injection) (Pentazocine)
Dosage: continuous intravenous (not otherwise specified)
Indication: Sedation
Start date: 2007-07-23
End date: 2007-07-28
Takepron (Lansoprazole) (Injection) (Lansoprazole)
Dosage: 60 mg (30 mg, 2 in 1 d), intravenous drip; 30 mg (30 mg, 1 in 1 d), per oral
Administration route: Oral
Indication: Gastric Ulcer
Start date: 2007-07-23
End date: 2007-08-03
Takepron (Lansoprazole) (Injection) (Lansoprazole)
Dosage: 60 mg (30 mg, 2 in 1 d), intravenous drip; 30 mg (30 mg, 1 in 1 d), per oral
Administration route: Oral
Indication: Gastric Ulcer
Start date: 2007-08-04
End date: 2007-08-21
Voltaren
Dosage: continuous intravenous ( otherwise not specified)
Indication: Hyperthermia
Start date: 2007-07-23
End date: 2007-08-05
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: female, weighing 63.6 kg (140.0 pounds)
Adverse reactions / side effects: Hepatic Neoplasm, Hepatic Cirrhosis
Suspect drug(s):
Norvasc (Amlodipine)
Other drugs received by patient: Hydrochlorothiazide; Levothroid; Lisinopril; Vitamin CAP; Iron; Folic Acid
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-10-24
Patient: female
Adverse reactions / side effects: Toxic Epidermal Necrolysis, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Apresoline
Administration route: Oral
Indication: Hypertension
Start date: 2007-07-30
End date: 2007-08-07
Baktar
Administration route: Oral
Start date: 2007-07-25
End date: 2007-08-01
Biapenem
Indication: Interstitial Lung Disease
Start date: 2007-07-23
End date: 2007-08-08
Dormicum FOR Injection
Indication: Sedation
Start date: 2007-07-23
End date: 2007-07-28
Elaspol
Lansoprazole
Indication: Gastric Ulcer
Start date: 2007-07-23
End date: 2007-08-03
Lansoprazole
Dosage: daily dose:30mg
Administration route: Oral
Start date: 2007-08-04
End date: 2007-08-21
Levofloxacin
Administration route: Oral
Start date: 2007-08-08
End date: 2007-08-12
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2007-08-08
End date: 2007-08-27
Olmetec
Administration route: Oral
Indication: Hypertension
Start date: 2007-08-08
End date: 2007-08-21
Pentazocine Lactate
Start date: 2007-07-23
End date: 2007-07-28
Prodif
Indication: Fungal Infection
Start date: 2007-07-23
End date: 2007-08-04
Voltaren
Dosage: daily dose:25mg-freq:frequency: prn
Indication: Pyrexia
Start date: 2007-07-23
End date: 2007-08-05
Other drugs received by patient: Flumetholon; Prednisolone
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from United States on 2007-10-23
Patient: female, weighing 95.5 kg (210.0 pounds)
Adverse reactions / side effects: Hypersensitivity, Pruritus, Tinnitus, Atrial Fibrillation, Rhinorrhoea, Skin Disorder, Myalgia, Body Height Decreased, Hypertension
Suspect drug(s):
Amlodipine
Indication: Hypertension
Arthrotec
Clindamycin HCL
Lipitor
Indication: Blood Cholesterol
Norvasc
Indication: Hypertension
Prednisone
Administration route: Oral
Other drugs received by patient: Synthroid; Triamterene and Hydrochlorothiazide; Toprol-XL; Propafenone HCL; Warfarin Sodium
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from United States on 2007-10-22
Patient: female, weighing 48.6 kg (107.0 pounds)
Adverse reactions / side effects: Heart Rate Decreased, Fatigue, Blood Pressure Fluctuation
Suspect drug(s):
Norvasc (Amlodipine)
Other drugs received by patient: Lipitor
Adverse event in male receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-10-22
Patient: male
Adverse reactions / side effects: Ageusia
Suspect drug(s):
Alcenol
Administration route: Oral
Indication: Hypertension
Bezafibrate
Administration route: Oral
Indication: Hyperlipidaemia
Detrusitol SR
Administration route: Oral
Indication: Hypertonic Bladder
Lipitor
Administration route: Oral
Indication: Hyperlipidaemia
Norvasc
Administration route: Oral
Indication: Hypertension
Other drugs received by patient: Avishot
Adverse event in 79 year old female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from United States on 2007-10-22
Patient: 79 year old female
Adverse reactions / side effects: Asthma, Cataract, Neuropathy Peripheral, Staphylococcal Infection, Fungal Infection, Oedema Peripheral, Dehydration, Aspergillosis, Depressed Mood, Hypertension
Adverse event resulted in: disablity
Suspect drug(s):
Alprazolam
Catapres-TTS-1
Edecrin
Isradipine
Nexium
Norvasc
Other drugs received by patient: Metoprolol; Neurontin
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from United States on 2007-10-22
Patient: female, weighing 46.8 kg (103.0 pounds)
Adverse reactions / side effects: Coeliac Disease, Type 1 Diabetes Mellitus
Adverse event resulted in: hospitalization
Suspect drug(s):
Amlodipine
Indication: Hypertension
Norvasc
Indication: Hypertension
Start date: 2006-10-01
End date: 2007-07-01
Other drugs received by patient: Coreg; Benicar; Doxazosin Mesylate
Adverse event in 59 year old female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from Australia on 2007-10-19
Patient: 59 year old female
Adverse reactions / side effects: Hypersensitivity, Pain in Extremity, Chromaturia, Constipation, Flushing, Dyspepsia, Dizziness, Gastrooesophageal Reflux Disease
Suspect drug(s):
Norvasc (Amlodipine)
Other drugs received by patient: Enalapril Maleate; Thiazides; Mobic; Tricyclic Antidepressants
|
